Logo image of AMST

AMESITE INC (AMST) Stock Fundamental Analysis

NASDAQ:AMST - Nasdaq - US0310942042 - Common Stock - Currency: USD

3.45  0 (0%)

Fundamental Rating

2

AMST gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 71 industry peers in the Diversified Consumer Services industry. AMST has a great financial health rating, but its profitability evaluates not so good. AMST is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AMST has reported negative net income.
AMST had a negative operating cash flow in the past year.
In the past 5 years AMST always reported negative net income.
AMST had a negative operating cash flow in each of the past 5 years.
AMST Yearly Net Income VS EBIT VS OCF VS FCFAMST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -136.60%, AMST is doing worse than 95.31% of the companies in the same industry.
Looking at the Return On Equity, with a value of -184.72%, AMST is doing worse than 79.69% of the companies in the same industry.
Industry RankSector Rank
ROA -136.6%
ROE -184.72%
ROIC N/A
ROA(3y)-100.08%
ROA(5y)-93.25%
ROE(3y)-118.19%
ROE(5y)-118.46%
ROIC(3y)N/A
ROIC(5y)N/A
AMST Yearly ROA, ROE, ROICAMST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200

1.3 Margins

AMST does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMST Yearly Profit, Operating, Gross MarginsAMST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 -10K -20K -30K

More info and screens

7

2. Health

2.1 Basic Checks

AMST does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AMST has about the same amount of shares outstanding.
The number of shares outstanding for AMST has been increased compared to 5 years ago.
AMST has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AMST Yearly Shares OutstandingAMST Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
AMST Yearly Total Debt VS Total AssetsAMST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

AMST has an Altman-Z score of -13.91. This is a bad value and indicates that AMST is not financially healthy and even has some risk of bankruptcy.
AMST has a Altman-Z score of -13.91. This is amonst the worse of the industry: AMST underperforms 87.50% of its industry peers.
AMST has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -13.91
ROIC/WACCN/A
WACC10.27%
AMST Yearly LT Debt VS Equity VS FCFAMST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 2.96 indicates that AMST has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.96, AMST is in the better half of the industry, outperforming 76.56% of the companies in the same industry.
A Quick Ratio of 2.96 indicates that AMST has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.96, AMST is in the better half of the industry, outperforming 78.13% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.96
Quick Ratio 2.96
AMST Yearly Current Assets VS Current LiabilitesAMST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

2

3. Growth

3.1 Past

AMST shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -25.29%.
Looking at the last year, AMST shows a very negative growth in Revenue. The Revenue has decreased by -81.58% in the last year.
The Revenue has been growing by 75.58% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-25.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.26%
Revenue 1Y (TTM)-81.58%
Revenue growth 3Y-37.08%
Revenue growth 5Y75.58%
Sales Q2Q%-82.24%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year150%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMST Yearly Revenue VS EstimatesAMST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
AMST Yearly EPS VS EstimatesAMST Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 -0.1 -0.2 -0.3 -0.4 -0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMST. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AMST. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMST Price Earnings VS Forward Price EarningsAMST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMST Per share dataAMST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AMST!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMESITE INC

NASDAQ:AMST (2/4/2025, 8:26:32 PM)

3.45

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)11-11 2024-11-11/amc
Earnings (Next)02-12 2025-02-12
Inst Owners7.28%
Inst Owner Change-17.63%
Ins Owners23.11%
Ins Owner Change1.8%
Market Cap9.63M
Analysts82.86
Price TargetN/A
Short Float %2.14%
Short Ratio0.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 83.85
P/FCF N/A
P/OCF N/A
P/B 4.02
P/tB 5.62
EV/EBITDA N/A
EPS(TTM)-1.72
EYN/A
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)-1.11
FCFYN/A
OCF(TTM)-0.95
OCFYN/A
SpS0.04
BVpS0.86
TBVpS0.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -136.6%
ROE -184.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-100.08%
ROA(5y)-93.25%
ROE(3y)-118.19%
ROE(5y)-118.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 91.81%
Cap/Sales 399.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.96
Quick Ratio 2.96
Altman-Z -13.91
F-Score2
WACC10.27%
ROIC/WACCN/A
Cap/Depr(3y)69.98%
Cap/Depr(5y)95.16%
Cap/Sales(3y)124.57%
Cap/Sales(5y)366.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-25.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.26%
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-81.58%
Revenue growth 3Y-37.08%
Revenue growth 5Y75.58%
Sales Q2Q%-82.24%
Revenue Next Year150%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-26.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y54.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.18%
OCF growth 3YN/A
OCF growth 5YN/A